These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36187921)

  • 1. Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis.
    Du Z; Wang Y; Liang J; Gao S; Cai X; Yu Y; Qi Z; Li J; Xie Y; Wang Z
    Comput Struct Biotechnol J; 2022; 20():5203-5217. PubMed ID: 36187921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
    Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
    Front Genet; 2022; 13():874896. PubMed ID: 35865011
    [No Abstract]   [Full Text] [Related]  

  • 3. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
    Peng S; Wang G; Cheng Z; Guo Z
    Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.
    Xiao Y; Yang K; Wang Z; Zhao M; Deng Y; Ji W; Zou Y; Qian C; Liu Y; Xiao H; Liu H
    Front Surg; 2021; 8():775194. PubMed ID: 35187044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
    Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
    Front Immunol; 2022; 13():841404. PubMed ID: 35265085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
    Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q
    Front Immunol; 2023; 14():1242972. PubMed ID: 37809064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
    Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
    Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
    Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
    [No Abstract]   [Full Text] [Related]  

  • 11. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas
    Huang X; Zhang F; He D; Ji X; Gao J; Liu W; Wang Y; Liu Q; Xin T
    Front Oncol; 2021; 11():646060. PubMed ID: 34094933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas.
    Zhang P; Liu G; Hu J; Chen S; Wang B; Peng P; Yu X; Guo D
    Front Immunol; 2022; 13():824586. PubMed ID: 35371015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.
    Guo Q; Xiao X; Zhang J
    Front Oncol; 2021; 11():654388. PubMed ID: 33898320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
    Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
    J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
    Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
    Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas.
    Zhou Z; Wei J; Jiang W
    Sci Rep; 2022 Mar; 12(1):5457. PubMed ID: 35361903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
    Chen J; Hou C; Zheng Z; Lin H; Lv G; Zhou D
    World Neurosurg; 2019 Oct; 130():e775-e785. PubMed ID: 31295606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
    Tang H; Liu W; Xu Z; Zhao J; Wang W; Yu Z; Wei M
    J Cell Mol Med; 2021 Jun; 25(12):5534-5546. PubMed ID: 33960636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.